Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Lonza
|
| gptkbp:acquisitionYear |
2023
|
| gptkbp:collaboratesWith |
various pharmaceutical companies
|
| gptkbp:country |
gptkb:Netherlands
|
| gptkbp:focusesOn |
antibody-drug conjugates
|
| gptkbp:foundedIn |
2010
|
| gptkbp:founder |
Floris van Delft
Luc Brunsveld |
| gptkbp:headquartersLocation |
gptkb:Netherlands
|
| https://www.w3.org/2000/01/rdf-schema#label |
Synaffix
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:specializesIn |
site-specific conjugation technology
|
| gptkbp:technology |
GlycoConnect
HydraSpace |
| gptkbp:website |
https://www.synaffix.com/
|
| gptkbp:bfsParent |
gptkb:MVentures
|
| gptkbp:bfsLayer |
8
|